Atara Biotherapeutics, Inc. - COM (ATRA)

Historical Portfolio Holders from Q4 2014 to Q2 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
83 M
Holdings value Q1 2024
$57.6 M
Value change Q1 2024
+$13.7 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
78
Number of buys Q1 2024
0
Number of sells Q1 2024
-2
Average buys Q1 2024 %
0
Average sells Q1 2024 %
0%
CUSIP
046513107
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 542 $5 K -$200 K $9.23 1
2024 Q1 83 M $57.6 M +$13.7 M $0.69 78
2023 Q4 62.9 M $32.3 M -$40.5 M $0.51 89
2023 Q3 85.2 M $126 M -$2.78 M $1.48 106
2023 Q2 89.6 M $144 M -$26.2 M $1.61 112
2023 Q1 103 M $298 M +$14.8 M $2.90 122
2022 Q4 97.3 M $319 M -$4.32 M $3.28 136
2022 Q3 90.4 M $342 M -$19 M $3.78 143
2022 Q2 99.8 M $777 M +$14 M $7.79 130
2022 Q1 97.8 M $909 M +$12.5 M $9.29 137
2021 Q4 93.2 M $1.47 B +$63.6 M $15.76 132
2021 Q3 87.8 M $1.57 B +$68.8 M $17.90 135
2021 Q2 84.1 M $1.31 B -$12.8 M $15.55 141
2021 Q1 86.1 M $1.24 B -$5.86 M $14.36 146
2020 Q4 86.5 M $1.7 B +$61.4 M $19.63 144
2020 Q3 82.4 M $1.07 B +$55.6 M $12.96 133
2020 Q2 76.4 M $1.11 B +$266 M $14.57 117
2020 Q1 59.7 M $507 M +$1.17 M $8.51 102
2019 Q4 61.1 M $1.01 B +$38.4 M $16.47 113
2019 Q3 59 M $833 M +$118 M $14.12 108
2019 Q2 50.3 M $1.01 B +$11.3 M $20.11 113
2019 Q1 48.8 M $1.94 B +$25.2 M $39.75 117
2018 Q4 48.3 M $1.68 B +$62.5 M $34.74 121
2018 Q3 46.3 M $1.92 B -$3.17 M $41.35 115
2018 Q2 46.5 M $1.71 B +$103 M $36.75 123
2018 Q1 43.6 M $1.7 B +$555 M $39.00 115
2017 Q4 29.8 M $541 M +$34.9 M $18.10 85
2017 Q3 26.6 M $441 M +$15.3 M $16.55 81
2017 Q2 25.7 M $360 M +$19.8 M $14.00 82
2017 Q1 24 M $493 M +$57.9 M $20.55 82
2016 Q4 23.2 M $329 M +$7.5 M $14.20 82
2016 Q3 22.4 M $479 M +$15.4 M $21.39 71
2016 Q2 21.6 M $486 M +$46.7 M $22.51 70
2016 Q1 19.8 M $377 M +$7.12 M $19.03 69
2015 Q4 19.3 M $509 M -$22 M $26.41 84
2015 Q3 19.5 M $612 M +$196 M $31.44 87
2015 Q2 13.2 M $696 M +$109 M $52.76 75
2015 Q1 11.2 M $462 M +$186 M $41.57 52
2014 Q4 6.73 M $172 M +$162 M $26.75 39